- $1.05bn
- $1.87bn
- $1.37bn
NYSE ORDER IMBALANCE 102771.0 SHARES ON BUY SIDE
NYSE ORDER IMBALANCE 100000.0 SHARES ON BUY SIDE
Brief: Conmed Corporation Announces Pricing Of Upsized $700 Million Offering Of Convertible Senior Notes
Conmed drops on $600 mln convertible debt offering
Brief: Conmed Corporation Announces Private Offering Of $600 Mln Of Convertible Senior Notes
Brief: Conmed Announces Definitive Agreement To Acquire In2bones Global, Inc.
Brief: Conmed Corporation Announces First Quarter 2022 Financial Results
NYSE ORDER IMBALANCE 63146.0 SHARES ON BUY SIDE
U.S. RESEARCH ROUNDUP-Cross Country Healthcare, First Solar, ServiceNow
Conmed Corp reports results for the quarter ended in December - Earnings Summary
Diagnostics, Williams-Sonoma, Cytokinetics
U.S. STOCKS ON THE MOVE-Vaccine makers, SeaChange, Voya Financial, BiondVax
U.S. STOCKS ON THE MOVE-Reliance Global, Allakos, Acasti Pharma, CalAmp Corp
Conmed Has Potential For Multiple Beat: and-raise quarters, says JPM
Conmed Corp reports results for the quarter ended in September - Earnings Summary
Brief: Conmed Corporation Sees FY Adjusted Earnings Per Share $3.18 TO $3.23
CONMED gains after Needham upgrades to 'buy' on strong revenue growth
NYSE ORDER IMBALANCE 52761.0 SHARES ON BUY SIDE
Brief: CONMED Corp Proposes Quarterly Cash Dividend Of $0.20 Per Share